カテゴリー： 世界, 医療/バイオ, LP Information

世界のOTC経皮鎮痛パッチ市場予測 2023年-2029年

【英語タイトル】Global OTC Transdermal Analgesic Patches Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC01835）・商品コード：LP23DC01835
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のOTC経皮鎮痛パッチ市場」は、過去の販売実績から2022年の世界のOTC経皮鎮痛パッチの総販売量を検討し、2023年から2029年の予測されるOTC経皮鎮痛パッチの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のOTC経皮鎮痛パッチの市場規模を掲載し、XXX百万米ドル規模の世界のOTC経皮鎮痛パッチ市場の詳細な分析を提供します。本インサイトレポートは、世界のOTC経皮鎮痛パッチ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のOTC経皮鎮痛パッチ市場における各社の独自のポジションをより深く理解するために、OTC経皮鎮痛パッチ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のOTC経皮鎮痛パッチ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。OTC経皮鎮痛パッチの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。OTC経皮鎮痛パッチの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。OTC経皮鎮痛パッチのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

OTC経皮鎮痛パッチの世界主要メーカーとしては、Hisamitsu、 Mylan、 Johnson & Johnson、 Teva、 Lingrui、 Sanofi、 Qizheng、 Endo、 Huarun 999、 GSK、 Haw Par、 Nichiban、 Laboratoires Genevrier、 BLUE-EMU、 IBSA Group、 Pfizer、 Performance Health、 Actavis、 Teikoku Seiyaku、 Novartisなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のOTC経皮鎮痛パッチ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではOTC経皮鎮痛パッチ市場をセグメンテーションし、種類別 (リドカインパッチ、ジクロフェナクパッチ、インドメタシンパッチ、抗刺激剤パッチ、その他)、用途別 (薬局、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：リドカインパッチ、ジクロフェナクパッチ、インドメタシンパッチ、抗刺激剤パッチ、その他

・用途別区分：薬局、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のOTC経皮鎮痛パッチ市場の10年間の市場状況・展望は？
・世界および地域別に見たOTC経皮鎮痛パッチ市場成長の要因は何か？
・OTC経皮鎮痛パッチの市場機会はエンドマーケットの規模によってどのように変化するのか？
・OTC経皮鎮痛パッチのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：OTC経皮鎮痛パッチの年間販売量2018-2029、地域別現状・将来分析
・OTC経皮鎮痛パッチの種類別セグメント：リドカインパッチ、ジクロフェナクパッチ、インドメタシンパッチ、抗刺激剤パッチ、その他
・OTC経皮鎮痛パッチの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・OTC経皮鎮痛パッチの用途別セグメント：薬局、診療所、その他
・OTC経皮鎮痛パッチの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のOTC経皮鎮痛パッチ市場
・企業別のグローバルOTC経皮鎮痛パッチ市場データ：2018-2023年の年間販売量、市場シェア
・企業別のOTC経皮鎮痛パッチの年間売上：2018-2023年の売上、市場シェア
・企業別のOTC経皮鎮痛パッチ販売価格
・主要企業のOTC経皮鎮痛パッチ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

OTC経皮鎮痛パッチの地域別レビュー
・地域別のOTC経皮鎮痛パッチ市場規模2018-2023：年間販売量、売上
・主要国別のOTC経皮鎮痛パッチ市場規模2018-2023：年間販売量、売上
・南北アメリカのOTC経皮鎮痛パッチ販売の成長
・アジア太平洋のOTC経皮鎮痛パッチ販売の成長
・ヨーロッパのOTC経皮鎮痛パッチ販売の成長
・中東・アフリカのOTC経皮鎮痛パッチ販売の成長

南北アメリカ市場
・南北アメリカの国別のOTC経皮鎮痛パッチ販売量、売上（2018-2023）
・南北アメリカのOTC経皮鎮痛パッチの種類別販売量
・南北アメリカのOTC経皮鎮痛パッチの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のOTC経皮鎮痛パッチ販売量、売上（2018-2023）
・アジア太平洋のOTC経皮鎮痛パッチの種類別販売量
・アジア太平洋のOTC経皮鎮痛パッチの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のOTC経皮鎮痛パッチ販売量、売上（2018-2023）
・ヨーロッパのOTC経皮鎮痛パッチの種類別販売量
・ヨーロッパのOTC経皮鎮痛パッチの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のOTC経皮鎮痛パッチ販売量、売上（2018-2023）
・中東・アフリカのOTC経皮鎮痛パッチの種類別販売量
・中東・アフリカのOTC経皮鎮痛パッチの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・OTC経皮鎮痛パッチの製造コスト構造分析
・OTC経皮鎮痛パッチの製造プロセス分析
・OTC経皮鎮痛パッチの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・OTC経皮鎮痛パッチの主要なグローバル販売業者
・OTC経皮鎮痛パッチの主要なグローバル顧客

地域別のOTC経皮鎮痛パッチ市場予測レビュー
・地域別のOTC経皮鎮痛パッチ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・OTC経皮鎮痛パッチの種類別市場規模予測
・OTC経皮鎮痛パッチの用途別市場規模予測

主要企業分析
Hisamitsu、 Mylan、 Johnson & Johnson、 Teva、 Lingrui、 Sanofi、 Qizheng、 Endo、 Huarun 999、 GSK、 Haw Par、 Nichiban、 Laboratoires Genevrier、 BLUE-EMU、 IBSA Group、 Pfizer、 Performance Health、 Actavis、 Teikoku Seiyaku、 Novartis
・企業情報
・OTC経皮鎮痛パッチ製品
・OTC経皮鎮痛パッチ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global OTC Transdermal Analgesic Patches market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for OTC Transdermal Analgesic Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for OTC Transdermal Analgesic Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for OTC Transdermal Analgesic Patches is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key OTC Transdermal Analgesic Patches players cover Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo and Huarun 999, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “OTC Transdermal Analgesic Patches Industry Forecast” looks at past sales and reviews total world OTC Transdermal Analgesic Patches sales in 2022, providing a comprehensive analysis by region and market sector of projected OTC Transdermal Analgesic Patches sales for 2023 through 2029. With OTC Transdermal Analgesic Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world OTC Transdermal Analgesic Patches industry.
This Insight Report provides a comprehensive analysis of the global OTC Transdermal Analgesic Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on OTC Transdermal Analgesic Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global OTC Transdermal Analgesic Patches market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for OTC Transdermal Analgesic Patches and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global OTC Transdermal Analgesic Patches.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Transdermal Analgesic Patches market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Others
Segmentation by application
Pharmacy
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Hisamitsu
Mylan
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
Actavis
Teikoku Seiyaku
Novartis
Key Questions Addressed in this Report
What is the 10-year outlook for the global OTC Transdermal Analgesic Patches market?
What factors are driving OTC Transdermal Analgesic Patches market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do OTC Transdermal Analgesic Patches market opportunities vary by end market size?
How does OTC Transdermal Analgesic Patches break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Transdermal Analgesic Patches Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for OTC Transdermal Analgesic Patches by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for OTC Transdermal Analgesic Patches by Country/Region, 2018, 2022 & 2029
2.2 OTC Transdermal Analgesic Patches Segment by Type
2.2.1 Lidocaine Patches
2.2.2 Diclofenac Patches
2.2.3 Indomethacin Patches
2.2.4 Counter-Irritant Patches
2.2.5 Others
2.3 OTC Transdermal Analgesic Patches Sales by Type
2.3.1 Global OTC Transdermal Analgesic Patches Sales Market Share by Type (2018-2023)
2.3.2 Global OTC Transdermal Analgesic Patches Revenue and Market Share by Type (2018-2023)
2.3.3 Global OTC Transdermal Analgesic Patches Sale Price by Type (2018-2023)
2.4 OTC Transdermal Analgesic Patches Segment by Application
2.4.1 Pharmacy
2.4.2 Clinic
2.4.3 Others
2.5 OTC Transdermal Analgesic Patches Sales by Application
2.5.1 Global OTC Transdermal Analgesic Patches Sale Market Share by Application (2018-2023)
2.5.2 Global OTC Transdermal Analgesic Patches Revenue and Market Share by Application (2018-2023)
2.5.3 Global OTC Transdermal Analgesic Patches Sale Price by Application (2018-2023)
3 Global OTC Transdermal Analgesic Patches by Company
3.1 Global OTC Transdermal Analgesic Patches Breakdown Data by Company
3.1.1 Global OTC Transdermal Analgesic Patches Annual Sales by Company (2018-2023)
3.1.2 Global OTC Transdermal Analgesic Patches Sales Market Share by Company (2018-2023)
3.2 Global OTC Transdermal Analgesic Patches Annual Revenue by Company (2018-2023)
3.2.1 Global OTC Transdermal Analgesic Patches Revenue by Company (2018-2023)
3.2.2 Global OTC Transdermal Analgesic Patches Revenue Market Share by Company (2018-2023)
3.3 Global OTC Transdermal Analgesic Patches Sale Price by Company
3.4 Key Manufacturers OTC Transdermal Analgesic Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers OTC Transdermal Analgesic Patches Product Location Distribution
3.4.2 Players OTC Transdermal Analgesic Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for OTC Transdermal Analgesic Patches by Geographic Region
4.1 World Historic OTC Transdermal Analgesic Patches Market Size by Geographic Region (2018-2023)
4.1.1 Global OTC Transdermal Analgesic Patches Annual Sales by Geographic Region (2018-2023)
4.1.2 Global OTC Transdermal Analgesic Patches Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic OTC Transdermal Analgesic Patches Market Size by Country/Region (2018-2023)
4.2.1 Global OTC Transdermal Analgesic Patches Annual Sales by Country/Region (2018-2023)
4.2.2 Global OTC Transdermal Analgesic Patches Annual Revenue by Country/Region (2018-2023)
4.3 Americas OTC Transdermal Analgesic Patches Sales Growth
4.4 APAC OTC Transdermal Analgesic Patches Sales Growth
4.5 Europe OTC Transdermal Analgesic Patches Sales Growth
4.6 Middle East & Africa OTC Transdermal Analgesic Patches Sales Growth
5 Americas
5.1 Americas OTC Transdermal Analgesic Patches Sales by Country
5.1.1 Americas OTC Transdermal Analgesic Patches Sales by Country (2018-2023)
5.1.2 Americas OTC Transdermal Analgesic Patches Revenue by Country (2018-2023)
5.2 Americas OTC Transdermal Analgesic Patches Sales by Type
5.3 Americas OTC Transdermal Analgesic Patches Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Transdermal Analgesic Patches Sales by Region
6.1.1 APAC OTC Transdermal Analgesic Patches Sales by Region (2018-2023)
6.1.2 APAC OTC Transdermal Analgesic Patches Revenue by Region (2018-2023)
6.2 APAC OTC Transdermal Analgesic Patches Sales by Type
6.3 APAC OTC Transdermal Analgesic Patches Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe OTC Transdermal Analgesic Patches by Country
7.1.1 Europe OTC Transdermal Analgesic Patches Sales by Country (2018-2023)
7.1.2 Europe OTC Transdermal Analgesic Patches Revenue by Country (2018-2023)
7.2 Europe OTC Transdermal Analgesic Patches Sales by Type
7.3 Europe OTC Transdermal Analgesic Patches Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Transdermal Analgesic Patches by Country
8.1.1 Middle East & Africa OTC Transdermal Analgesic Patches Sales by Country (2018-2023)
8.1.2 Middle East & Africa OTC Transdermal Analgesic Patches Revenue by Country (2018-2023)
8.2 Middle East & Africa OTC Transdermal Analgesic Patches Sales by Type
8.3 Middle East & Africa OTC Transdermal Analgesic Patches Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of OTC Transdermal Analgesic Patches
10.3 Manufacturing Process Analysis of OTC Transdermal Analgesic Patches
10.4 Industry Chain Structure of OTC Transdermal Analgesic Patches
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 OTC Transdermal Analgesic Patches Distributors
11.3 OTC Transdermal Analgesic Patches Customer
12 World Forecast Review for OTC Transdermal Analgesic Patches by Geographic Region
12.1 Global OTC Transdermal Analgesic Patches Market Size Forecast by Region
12.1.1 Global OTC Transdermal Analgesic Patches Forecast by Region (2024-2029)
12.1.2 Global OTC Transdermal Analgesic Patches Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global OTC Transdermal Analgesic Patches Forecast by Type
12.7 Global OTC Transdermal Analgesic Patches Forecast by Application
13 Key Players Analysis
13.1 Hisamitsu
13.1.1 Hisamitsu Company Information
13.1.2 Hisamitsu OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.1.3 Hisamitsu OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hisamitsu Main Business Overview
13.1.5 Hisamitsu Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.2.3 Mylan OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.4.3 Teva OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Lingrui
13.5.1 Lingrui Company Information
13.5.2 Lingrui OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.5.3 Lingrui OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lingrui Main Business Overview
13.5.5 Lingrui Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.6.3 Sanofi OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 Qizheng
13.7.1 Qizheng Company Information
13.7.2 Qizheng OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.7.3 Qizheng OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Qizheng Main Business Overview
13.7.5 Qizheng Latest Developments
13.8 Endo
13.8.1 Endo Company Information
13.8.2 Endo OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.8.3 Endo OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endo Main Business Overview
13.8.5 Endo Latest Developments
13.9 Huarun 999
13.9.1 Huarun 999 Company Information
13.9.2 Huarun 999 OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.9.3 Huarun 999 OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Huarun 999 Main Business Overview
13.9.5 Huarun 999 Latest Developments
13.10 GSK
13.10.1 GSK Company Information
13.10.2 GSK OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.10.3 GSK OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GSK Main Business Overview
13.10.5 GSK Latest Developments
13.11 Haw Par
13.11.1 Haw Par Company Information
13.11.2 Haw Par OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.11.3 Haw Par OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Haw Par Main Business Overview
13.11.5 Haw Par Latest Developments
13.12 Nichiban
13.12.1 Nichiban Company Information
13.12.2 Nichiban OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.12.3 Nichiban OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nichiban Main Business Overview
13.12.5 Nichiban Latest Developments
13.13 Laboratoires Genevrier
13.13.1 Laboratoires Genevrier Company Information
13.13.2 Laboratoires Genevrier OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Laboratoires Genevrier Main Business Overview
13.13.5 Laboratoires Genevrier Latest Developments
13.14 BLUE-EMU
13.14.1 BLUE-EMU Company Information
13.14.2 BLUE-EMU OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 BLUE-EMU Main Business Overview
13.14.5 BLUE-EMU Latest Developments
13.15 IBSA Group
13.15.1 IBSA Group Company Information
13.15.2 IBSA Group OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.15.3 IBSA Group OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 IBSA Group Main Business Overview
13.15.5 IBSA Group Latest Developments
13.16 Pfizer
13.16.1 Pfizer Company Information
13.16.2 Pfizer OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.16.3 Pfizer OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Pfizer Main Business Overview
13.16.5 Pfizer Latest Developments
13.17 Performance Health
13.17.1 Performance Health Company Information
13.17.2 Performance Health OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.17.3 Performance Health OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Performance Health Main Business Overview
13.17.5 Performance Health Latest Developments
13.18 Actavis
13.18.1 Actavis Company Information
13.18.2 Actavis OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.18.3 Actavis OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Actavis Main Business Overview
13.18.5 Actavis Latest Developments
13.19 Teikoku Seiyaku
13.19.1 Teikoku Seiyaku Company Information
13.19.2 Teikoku Seiyaku OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Teikoku Seiyaku Main Business Overview
13.19.5 Teikoku Seiyaku Latest Developments
13.20 Novartis
13.20.1 Novartis Company Information
13.20.2 Novartis OTC Transdermal Analgesic Patches Product Portfolios and Specifications
13.20.3 Novartis OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Novartis Main Business Overview
13.20.5 Novartis Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. OTC Transdermal Analgesic Patches Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. OTC Transdermal Analgesic Patches Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Lidocaine Patches
Table 4. Major Players of Diclofenac Patches
Table 5. Major Players of Indomethacin Patches
Table 6. Major Players of Counter-Irritant Patches
Table 7. Major Players of Others
Table 8. Global OTC Transdermal Analgesic Patches Sales by Type (2018-2023) & (K Units)
Table 9. Global OTC Transdermal Analgesic Patches Sales Market Share by Type (2018-2023)
Table 10. Global OTC Transdermal Analgesic Patches Revenue by Type (2018-2023) & ($ million)
Table 11. Global OTC Transdermal Analgesic Patches Revenue Market Share by Type (2018-2023)
Table 12. Global OTC Transdermal Analgesic Patches Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global OTC Transdermal Analgesic Patches Sales by Application (2018-2023) & (K Units)
Table 14. Global OTC Transdermal Analgesic Patches Sales Market Share by Application (2018-2023)
Table 15. Global OTC Transdermal Analgesic Patches Revenue by Application (2018-2023)
Table 16. Global OTC Transdermal Analgesic Patches Revenue Market Share by Application (2018-2023)
Table 17. Global OTC Transdermal Analgesic Patches Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global OTC Transdermal Analgesic Patches Sales by Company (2018-2023) & (K Units)
Table 19. Global OTC Transdermal Analgesic Patches Sales Market Share by Company (2018-2023)
Table 20. Global OTC Transdermal Analgesic Patches Revenue by Company (2018-2023) ($ Millions)
Table 21. Global OTC Transdermal Analgesic Patches Revenue Market Share by Company (2018-2023)
Table 22. Global OTC Transdermal Analgesic Patches Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers OTC Transdermal Analgesic Patches Producing Area Distribution and Sales Area
Table 24. Players OTC Transdermal Analgesic Patches Products Offered
Table 25. OTC Transdermal Analgesic Patches Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global OTC Transdermal Analgesic Patches Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global OTC Transdermal Analgesic Patches Sales Market Share Geographic Region (2018-2023)
Table 30. Global OTC Transdermal Analgesic Patches Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global OTC Transdermal Analgesic Patches Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global OTC Transdermal Analgesic Patches Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global OTC Transdermal Analgesic Patches Sales Market Share by Country/Region (2018-2023)
Table 34. Global OTC Transdermal Analgesic Patches Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global OTC Transdermal Analgesic Patches Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas OTC Transdermal Analgesic Patches Sales by Country (2018-2023) & (K Units)
Table 37. Americas OTC Transdermal Analgesic Patches Sales Market Share by Country (2018-2023)
Table 38. Americas OTC Transdermal Analgesic Patches Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas OTC Transdermal Analgesic Patches Revenue Market Share by Country (2018-2023)
Table 40. Americas OTC Transdermal Analgesic Patches Sales by Type (2018-2023) & (K Units)
Table 41. Americas OTC Transdermal Analgesic Patches Sales by Application (2018-2023) & (K Units)
Table 42. APAC OTC Transdermal Analgesic Patches Sales by Region (2018-2023) & (K Units)
Table 43. APAC OTC Transdermal Analgesic Patches Sales Market Share by Region (2018-2023)
Table 44. APAC OTC Transdermal Analgesic Patches Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC OTC Transdermal Analgesic Patches Revenue Market Share by Region (2018-2023)
Table 46. APAC OTC Transdermal Analgesic Patches Sales by Type (2018-2023) & (K Units)
Table 47. APAC OTC Transdermal Analgesic Patches Sales by Application (2018-2023) & (K Units)
Table 48. Europe OTC Transdermal Analgesic Patches Sales by Country (2018-2023) & (K Units)
Table 49. Europe OTC Transdermal Analgesic Patches Sales Market Share by Country (2018-2023)
Table 50. Europe OTC Transdermal Analgesic Patches Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe OTC Transdermal Analgesic Patches Revenue Market Share by Country (2018-2023)
Table 52. Europe OTC Transdermal Analgesic Patches Sales by Type (2018-2023) & (K Units)
Table 53. Europe OTC Transdermal Analgesic Patches Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa OTC Transdermal Analgesic Patches Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa OTC Transdermal Analgesic Patches Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa OTC Transdermal Analgesic Patches Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa OTC Transdermal Analgesic Patches Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa OTC Transdermal Analgesic Patches Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa OTC Transdermal Analgesic Patches Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of OTC Transdermal Analgesic Patches
Table 61. Key Market Challenges & Risks of OTC Transdermal Analgesic Patches
Table 62. Key Industry Trends of OTC Transdermal Analgesic Patches
Table 63. OTC Transdermal Analgesic Patches Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. OTC Transdermal Analgesic Patches Distributors List
Table 66. OTC Transdermal Analgesic Patches Customer List
Table 67. Global OTC Transdermal Analgesic Patches Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global OTC Transdermal Analgesic Patches Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas OTC Transdermal Analgesic Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas OTC Transdermal Analgesic Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC OTC Transdermal Analgesic Patches Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC OTC Transdermal Analgesic Patches Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe OTC Transdermal Analgesic Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe OTC Transdermal Analgesic Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa OTC Transdermal Analgesic Patches Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa OTC Transdermal Analgesic Patches Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global OTC Transdermal Analgesic Patches Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global OTC Transdermal Analgesic Patches Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global OTC Transdermal Analgesic Patches Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global OTC Transdermal Analgesic Patches Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Hisamitsu Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 82. Hisamitsu OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 83. Hisamitsu OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Hisamitsu Main Business
Table 85. Hisamitsu Latest Developments
Table 86. Mylan Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 87. Mylan OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 88. Mylan OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Mylan Main Business
Table 90. Mylan Latest Developments
Table 91. Johnson & Johnson Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 92. Johnson & Johnson OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 93. Johnson & Johnson OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Johnson & Johnson Main Business
Table 95. Johnson & Johnson Latest Developments
Table 96. Teva Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 97. Teva OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 98. Teva OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Teva Main Business
Table 100. Teva Latest Developments
Table 101. Lingrui Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 102. Lingrui OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 103. Lingrui OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Lingrui Main Business
Table 105. Lingrui Latest Developments
Table 106. Sanofi Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 108. Sanofi OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Sanofi Main Business
Table 110. Sanofi Latest Developments
Table 111. Qizheng Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 112. Qizheng OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 113. Qizheng OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Qizheng Main Business
Table 115. Qizheng Latest Developments
Table 116. Endo Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 117. Endo OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 118. Endo OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Endo Main Business
Table 120. Endo Latest Developments
Table 121. Huarun 999 Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 122. Huarun 999 OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 123. Huarun 999 OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Huarun 999 Main Business
Table 125. Huarun 999 Latest Developments
Table 126. GSK Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 127. GSK OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 128. GSK OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. GSK Main Business
Table 130. GSK Latest Developments
Table 131. Haw Par Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 132. Haw Par OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 133. Haw Par OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Haw Par Main Business
Table 135. Haw Par Latest Developments
Table 136. Nichiban Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 137. Nichiban OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 138. Nichiban OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Nichiban Main Business
Table 140. Nichiban Latest Developments
Table 141. Laboratoires Genevrier Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 142. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 143. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. Laboratoires Genevrier Main Business
Table 145. Laboratoires Genevrier Latest Developments
Table 146. BLUE-EMU Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 147. BLUE-EMU OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 148. BLUE-EMU OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. BLUE-EMU Main Business
Table 150. BLUE-EMU Latest Developments
Table 151. IBSA Group Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 152. IBSA Group OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 153. IBSA Group OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. IBSA Group Main Business
Table 155. IBSA Group Latest Developments
Table 156. Pfizer Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 157. Pfizer OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 158. Pfizer OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Pfizer Main Business
Table 160. Pfizer Latest Developments
Table 161. Performance Health Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 162. Performance Health OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 163. Performance Health OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Performance Health Main Business
Table 165. Performance Health Latest Developments
Table 166. Actavis Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 167. Actavis OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 168. Actavis OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 169. Actavis Main Business
Table 170. Actavis Latest Developments
Table 171. Teikoku Seiyaku Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 172. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 173. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 174. Teikoku Seiyaku Main Business
Table 175. Teikoku Seiyaku Latest Developments
Table 176. Novartis Basic Information, OTC Transdermal Analgesic Patches Manufacturing Base, Sales Area and Its Competitors
Table 177. Novartis OTC Transdermal Analgesic Patches Product Portfolios and Specifications
Table 178. Novartis OTC Transdermal Analgesic Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 179. Novartis Main Business
Table 180. Novartis Latest Developments
List of Figures
Figure 1. Picture of OTC Transdermal Analgesic Patches
Figure 2. OTC Transdermal Analgesic Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global OTC Transdermal Analgesic Patches Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global OTC Transdermal Analgesic Patches Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. OTC Transdermal Analgesic Patches Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Lidocaine Patches
Figure 10. Product Picture of Diclofenac Patches
Figure 11. Product Picture of Indomethacin Patches
Figure 12. Product Picture of Counter-Irritant Patches
Figure 13. Product Picture of Others
Figure 14. Global OTC Transdermal Analgesic Patches Sales Market Share by Type in 2022
Figure 15. Global OTC Transdermal Analgesic Patches Revenue Market Share by Type (2018-2023)
Figure 16. OTC Transdermal Analgesic Patches Consumed in Pharmacy
Figure 17. Global OTC Transdermal Analgesic Patches Market: Pharmacy (2018-2023) & (K Units)
Figure 18. OTC Transdermal Analgesic Patches Consumed in Clinic
Figure 19. Global OTC Transdermal Analgesic Patches Market: Clinic (2018-2023) & (K Units)
Figure 20. OTC Transdermal Analgesic Patches Consumed in Others
Figure 21. Global OTC Transdermal Analgesic Patches Market: Others (2018-2023) & (K Units)
Figure 22. Global OTC Transdermal Analgesic Patches Sales Market Share by Application (2022)
Figure 23. Global OTC Transdermal Analgesic Patches Revenue Market Share by Application in 2022
Figure 24. OTC Transdermal Analgesic Patches Sales Market by Company in 2022 (K Units)
Figure 25. Global OTC Transdermal Analgesic Patches Sales Market Share by Company in 2022
Figure 26. OTC Transdermal Analgesic Patches Revenue Market by Company in 2022 ($ Million)
Figure 27. Global OTC Transdermal Analgesic Patches Revenue Market Share by Company in 2022
Figure 28. Global OTC Transdermal Analgesic Patches Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global OTC Transdermal Analgesic Patches Revenue Market Share by Geographic Region in 2022
Figure 30. Americas OTC Transdermal Analgesic Patches Sales 2018-2023 (K Units)
Figure 31. Americas OTC Transdermal Analgesic Patches Revenue 2018-2023 ($ Millions)
Figure 32. APAC OTC Transdermal Analgesic Patches Sales 2018-2023 (K Units)
Figure 33. APAC OTC Transdermal Analgesic Patches Revenue 2018-2023 ($ Millions)
Figure 34. Europe OTC Transdermal Analgesic Patches Sales 2018-2023 (K Units)
Figure 35. Europe OTC Transdermal Analgesic Patches Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa OTC Transdermal Analgesic Patches Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa OTC Transdermal Analgesic Patches Revenue 2018-2023 ($ Millions)
Figure 38. Americas OTC Transdermal Analgesic Patches Sales Market Share by Country in 2022
Figure 39. Americas OTC Transdermal Analgesic Patches Revenue Market Share by Country in 2022
Figure 40. Americas OTC Transdermal Analgesic Patches Sales Market Share by Type (2018-2023)
Figure 41. Americas OTC Transdermal Analgesic Patches Sales Market Share by Application (2018-2023)
Figure 42. United States OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC OTC Transdermal Analgesic Patches Sales Market Share by Region in 2022
Figure 47. APAC OTC Transdermal Analgesic Patches Revenue Market Share by Regions in 2022
Figure 48. APAC OTC Transdermal Analgesic Patches Sales Market Share by Type (2018-2023)
Figure 49. APAC OTC Transdermal Analgesic Patches Sales Market Share by Application (2018-2023)
Figure 50. China OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 54. India OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe OTC Transdermal Analgesic Patches Sales Market Share by Country in 2022
Figure 58. Europe OTC Transdermal Analgesic Patches Revenue Market Share by Country in 2022
Figure 59. Europe OTC Transdermal Analgesic Patches Sales Market Share by Type (2018-2023)
Figure 60. Europe OTC Transdermal Analgesic Patches Sales Market Share by Application (2018-2023)
Figure 61. Germany OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 62. France OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa OTC Transdermal Analgesic Patches Sales Market Share by Country in 2022
Figure 67. Middle East & Africa OTC Transdermal Analgesic Patches Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa OTC Transdermal Analgesic Patches Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa OTC Transdermal Analgesic Patches Sales Market Share by Application (2018-2023)
Figure 70. Egypt OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country OTC Transdermal Analgesic Patches Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of OTC Transdermal Analgesic Patches in 2022
Figure 76. Manufacturing Process Analysis of OTC Transdermal Analgesic Patches
Figure 77. Industry Chain Structure of OTC Transdermal Analgesic Patches
Figure 78. Channels of Distribution
Figure 79. Global OTC Transdermal Analgesic Patches Sales Market Forecast by Region (2024-2029)
Figure 80. Global OTC Transdermal Analgesic Patches Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global OTC Transdermal Analgesic Patches Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global OTC Transdermal Analgesic Patches Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global OTC Transdermal Analgesic Patches Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global OTC Transdermal Analgesic Patches Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のOTC経皮鎮痛パッチ市場予測 2023年-2029年] (コード：LP23DC01835)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のOTC経皮鎮痛パッチ市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の粘着性鎮痛パッチ市場予測 2023年-2029年
  • 世界の医療用ニコチン経皮パッチ市場予測 2023年-2029年
  • 世界の経皮投薬型スキンパッチ市場予測2023-2029：接着剤中の薬剤、マトリックス、リザーバー、蒸気、その他
  • 世界の黄疸用非侵襲性機器市場予測 2023年-2029年
  • 世界のウェアラブル温度監視装置市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆